atenolol has been researched along with ARPKD in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrison, JL | 1 |
| Hildreth, CM | 1 |
| Callahan, SM | 1 |
| Goodchild, AK | 1 |
| Phillips, JK | 1 |
1 other study available for atenolol and ARPKD
| Article | Year |
|---|---|
Cardiovascular autonomic dysfunction in a novel rodent model of polycystic kidney disease.
Topics: Animals; Antihypertensive Agents; Atenolol; Atropine Derivatives; Autonomic Nervous System; Barorefl | 2010 |